These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 21832239)

  • 41. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
    Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
    Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response.
    Karl S; Pritschow Y; Volcic M; Häcker S; Baumann B; Wiesmüller L; Debatin KM; Fulda S
    J Cell Mol Med; 2009 Oct; 13(10):4239-56. PubMed ID: 19725919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
    Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
    J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antagonizing binding of cell cycle and apoptosis regulatory protein 1 (CARP-1) to the NEMO/IKKγ protein enhances the anticancer effect of chemotherapy.
    Venkatesh J; Sekhar SC; Cheriyan VT; Muthu M; Meister P; Levi E; Dzinic S; Gauld JW; Polin LA; Rishi AK
    J Biol Chem; 2020 Mar; 295(11):3532-3552. PubMed ID: 32024692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Function of polo-like kinase 3 in NF-kappaB-mediated proapoptotic response.
    Li Z; Niu J; Uwagawa T; Peng B; Chiao PJ
    J Biol Chem; 2005 Apr; 280(17):16843-50. PubMed ID: 15671037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hexabromocyclododecane and polychlorinated biphenyls increase resistance of hepatocellular carcinoma cells to cisplatin through the phosphatidylinositol 3-kinase/protein kinase B pathway.
    An J; Wang X; Guo P; Zhong Y; Zhang X; Yu Z
    Toxicol Lett; 2014 Aug; 229(1):265-72. PubMed ID: 24960055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors.
    Gurova KV; Hill JE; Guo C; Prokvolit A; Burdelya LG; Samoylova E; Khodyakova AV; Ganapathi R; Ganapathi M; Tararova ND; Bosykh D; Lvovskiy D; Webb TR; Stark GR; Gudkov AV
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17448-53. PubMed ID: 16287968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 7b, a novel amonafide analog, inhibited proliferation and phorbol 12-myristate 13-acetate/phytohemagglutinin-induced inflammatory responses of Jurkat T cells via p73-dependent pathway and decrease of nuclear factor-κB DNA-binding, respectively.
    Shao J; Li Y; Shen K; Lin B; Xu Y; Lu Y; Yin P; Li Q; Liu J; Qian X
    Leuk Lymphoma; 2013 Feb; 54(2):359-71. PubMed ID: 22762546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-apoptotic NF-κB and "gain of function" mutp53 in concert act pro-apoptotic in response to UVB+IL-1 via enhanced TNF production.
    Müller I; Beissert S; Kulms D
    J Invest Dermatol; 2015 Mar; 135(3):851-860. PubMed ID: 25380350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.
    Jeong SJ; Radonovich M; Brady JN; Pise-Masison CA
    Blood; 2004 Sep; 104(5):1490-7. PubMed ID: 15155458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cross talk between stimulated NF-kappaB and the tumor suppressor p53.
    Schneider G; Henrich A; Greiner G; Wolf V; Lovas A; Wieczorek M; Wagner T; Reichardt S; von Werder A; Schmid RM; Weih F; Heinzel T; Saur D; Krämer OH
    Oncogene; 2010 May; 29(19):2795-806. PubMed ID: 20190799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mycoepoxydiene, a fungal polyketide inhibits MCF-7 cells through simultaneously targeting p53 and NF-κB pathways.
    Wang J; Zhao B; Yi Y; Zhang W; Wu X; Zhang L; Shen Y
    Biochem Pharmacol; 2012 Oct; 84(7):891-9. PubMed ID: 22796259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rugulactone derivatives act as inhibitors of NF-κB activation and modulates the transcription of NF-κB dependent genes in MDA-MB-231cells.
    Mohapatra DK; Reddy DS; Ramaiah MJ; Ghosh S; Pothula V; Lunavath S; Thomas S; Valli SN; Bhadra MP; Yadav JS
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1389-96. PubMed ID: 24508135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.
    Paranjpe A; Srivenugopal KS
    Carcinogenesis; 2013 May; 34(5):990-1000. PubMed ID: 23354308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons.
    Culmsee C; Siewe J; Junker V; Retiounskaia M; Schwarz S; Camandola S; El-Metainy S; Behnke H; Mattson MP; Krieglstein J
    J Neurosci; 2003 Sep; 23(24):8586-95. PubMed ID: 13679428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers.
    Garcia H; Miecznikowski JC; Safina A; Commane M; Ruusulehto A; Kilpinen S; Leach RW; Attwood K; Li Y; Degan S; Omilian AR; Guryanova O; Papantonopoulou O; Wang J; Buck M; Liu S; Morrison C; Gurova KV
    Cell Rep; 2013 Jul; 4(1):159-73. PubMed ID: 23831030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade.
    Jia QP; Yan CY; Zheng XR; Pan X; Cao X; Cao L
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):625-637. PubMed ID: 30631898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct functional properties of IkappaB alpha and IkappaB beta.
    Tran K; Merika M; Thanos D
    Mol Cell Biol; 1997 Sep; 17(9):5386-99. PubMed ID: 9271416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.
    Carter DR; Murray J; Cheung BB; Gamble L; Koach J; Tsang J; Sutton S; Kalla H; Syed S; Gifford AJ; Issaeva N; Biktasova A; Atmadibrata B; Sun Y; Sokolowski N; Ling D; Kim PY; Webber H; Clark A; Ruhle M; Liu B; Oberthuer A; Fischer M; Byrne J; Saletta F; Thwe le M; Purmal A; Haderski G; Burkhart C; Speleman F; De Preter K; Beckers A; Ziegler DS; Liu T; Gurova KV; Gudkov AV; Norris MD; Haber M; Marshall GM
    Sci Transl Med; 2015 Nov; 7(312):312ra176. PubMed ID: 26537256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.